Brooks Laboratories Ltd BROOKS-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 10:06 AM IST
90.85quote price arrow down-1.25 (-1.36%)
Volume
49,314
52 week range
69.90 - 154.40
Loading...
  • Open91.85
  • Day High94.15
  • Day Low90.55
  • Prev Close92.10
  • 52 Week High154.40
  • 52 Week High Date09/16/21
  • 52 Week Low69.90
  • 52 Week Low Date05/11/22

Key Stats

  • Market Cap26.04M
  • Shares Out24.7M
  • 10 Day Average Volume67,499.2
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-10.05

KEY STATS

  • Open91.85
  • Day High94.15
  • Day Low90.55
  • Prev Close92.10
  • 52 Week High154.40
  • 52 Week High Date09/16/21
  • 52 Week Low69.90
  • 52 Week Low Date05/11/22
  • Market Cap26.04M
  • Shares Out24.7M
  • 10 Day Average Volume67,499.2
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-10.05

RATIOS/PROFITABILITY

  • EPS (TTM)-12.13
  • P/E (TTM)-7.49
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Brooks Laboratories Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Brooks Laboratories Limited is an India-based pharmaceutical manufacturing company working on a contract basis. The Company operates through the Pharmaceuticals segment. It manufactures various pharmaceutical dosage forms, including injections, tablets, dry syrup and eye/ear drops. Its products under Carbapenem category includes Imipenem 250mg + Cilastatin 250mg, Imipenem 500mg + Cilastatin 500mg, Meropenem 125mg, Meropenem 250mg, Meropenem 500mg, Meropenem 1000mg, Meropenem...
Atul Ranchal
Executive Chairman of the Board
Durga Maity
Chief Executive Officer, Executive Director - Technical, Director
Anil Pillai
Chief Financial Officer
Address
502 Andheri, Andheri Kurla Road
Mumbai
400093
India